Table 1. Means (M) and Standard Deviations (SD) of Subject Variables and ANOVA Results.
|
Haloperidol, n=18 |
Placebo, n=17 |
Levodopa, n=18 |
F (2, 52) |
p-Value |
|
|---|---|---|---|---|---|
| M±SD | M±SD | M±SD | |||
| Age | 22.39±3.58 | 21.11±3.04 | 24.61±8.07 | 1.87 | 0.17 |
| BMI | 22.86±2.37 | 22.31±2.39 | 22.31±1.65 | 0.38 | 0.68 |
| SCL-90 | 106.17±14.50 | 106.00±13.69 | 104.94±9.42 | 0.05 | 0.95 |
| BisBas-total | 42.44±6.29 | 41.00±6.39 | 41.00±5.41 | 0.34 | 0.71 |
| Bas-R | 8.78±2.78 | 8.58±2.06 | 9.06±2.53 | 0.16 | 0.86 |
| Bas-Fun | 7.05±1.51 | 7.88±1.97 | 7.23±1.96 | 0.96 | 0.39 |
| Bas-Drive | 7.22±2.11 | 7.17±1.67 | 7.83±2.79 | 0.42 | 0.66 |
| Barratt-BIS | 65.56±6.64 | 63.35±9.61 | 67.18±10.98 | 0.74 | 0.48 |
| SES-total | 48.89±4.40 | 49.71±6.34 | 51.71±5.25 | 1.26 | 0.29 |
| SIS1 | 36.72±3.53 | 38.76±2.86 | 37.76±4.56 | 1.32 | 0.28 |
| SIS2 | 27.28±1.96 | 27.76±2.70 | 28.59±2.93 | 1.17 | 0.32 |
| SAI-Anx | −1.56±1.85 | −1.41±1.69 | −1.51±1.42 | 0.04 | 0.96 |
| SAI-Aro | 142.28±21.47 | 143.53±23.79 | 143.11±21.36 | 0.02 | 0.99 |
Note: BMI, body mass index; BIS-BAS total, Behavioral Inhibition Behavioral activation Scale Score; Barratt-BIS, Barratt Impulsiveness Scale; Bas R, Reward Responsiveness; SAI-Anx, Sexual Arousability Index-Anxiety; SAI-Aro, Sexual Arousability Index-Arousability; SCL-90, Symptom Checklist-90; SES-total, SIS1 and SIS2, Sexual Excitation and Sexual Inhibition Scales.